Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Brake through in the development therapies for psoriasis and multiple sclerosis

19.10.2011
Multiple sclerosis and psoriasis are two of the most common autoimmune diseases. Most surprisingly, almost any therapy effective in one of the two diseases causes rather harm in the other, even though similar modes of inflammation underlie both diseases.

A research group of the Tübingen University Hospital studied a small, body-derived molecule called di-methyl fumarate (DMF), hat is the first molecule improving both diseases psoriasis and multiple sclerosis. They found that this body-derived molecule strongly influences natures most potent ‘immune stimulators’, the dendritic cells that have recently been awarded by the Nobel Prize to Ralph Steinman.

Normally, dendritic cells should recognize danger caused by bacteria or viruses, alarm the immune system and raise protective responses. Unfortunately, when fooled, dendritic cells induce by error immunity against the body’s own cells and start to destroy them.

The Tübingen team has now shown, that small molecules like DMF re-educate the dendritic cells and turn them into a cell that protects from tissue destruction, the so-called ‚type 2 dendritic cells’. Using complex series of experiments, they uncover the mechanisms underly-ing this ‘re-education of the dendritic cells’. This establishes general rules for the develop-ment of new, most likely safe drugs that will significantly improve the life of patients with se-vere autoimmune diseases, namely psoriasis or multiple sclerosis.

The University of Tübingen holds a patent on this principle.

Published in the Journal of Experimental Medicine 2011, October online
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells.
Ghoreschi K, Brück J, Kellerer C, Deng C, Peng H, Rothfuss O, Hussain RZ, Gocke AR, Respa A, Glocova I, Valtcheva N, Alexander E, Feil S, Feil R, Schulze-Osthoff K, Rupec RA, Lovett-Racke AE, Dringen R, Racke MK, Röcken M.
J Exp Med. 2011 Oct 10. [Epub ahead of print] PMID:21987655
DOI 10.1084/jem.20100977
Correspondence
University Hospital Tübingen
Department of Dermatology
Prof. Martin Röcken
Liebermeisterstr. 25, Tübingen, Germany
mrocken@med.uni-tuebingen.de

Dr. Ellen Katz | idw
Further information:
http://www.uni-tuebingen.de

Further reports about: DMF autoimmune disease dendritic cells multiple sclerosis

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

Construction of practical quantum computers radically simplified

05.12.2016 | Information Technology

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>